IBO Impact BioMedical Inc: Net Sales Margin

Brandmark of impactbiomedinc.com (IBO)

Monetization prospects for the early research of Impact BioMedical Inc (IBO) remain long-term, which is why the net sales margin spread on GURU.Markets shows the current metric is 4247.40. High profitability is driven by patents for antioxidant molecules. Stable income is based on the licensing of bioprotective technologies, which minimizes costs and guarantees a constant cash flow from the use of mature medical solutions.

IBO: Impact BioMedical, Inc. Company Net Profitability 09/17/2024 - 11/19/2026

Financial and market metric breakdowns for Impact BioMedical (IBO)

Analysis of all company metrics:Impact BioMedical Inc
Flagship merchandise of impactbiomedinc.com

Impact BioMedical Inc (IBO) maintains a strong position thanks to a diversified ecosystem of biomedical developments. By analyzing the net profit margin, an investor assesses the monetization efficiency of antiviral and diabetic drugs. This ratio determines the share of net profit in total sales, measuring the business's ultimate operating efficiency. Growth in this metric confirms a high return on invested capital. The market views a stable trend as a guarantee of resilience against external shocks.

Analysis of competing companies

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|LEXX - Net Margin|Net Sales Margin PULM (pulmatrix.com)|Company Net Profitability PTHL (Pheton)|APM - Net Margin|Company Sales Margin Lyra Therapeutics Inc LYRA|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma